Literature DB >> 27535042

Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.

Christopher Wu1, Jason R Kovac2.   

Abstract

There has recently been renewed interest in novel clinical applications of the anabolic-androgenic steroid (AAS) testosterone and its synthetic derivatives, particularly given with the rising popularity of testosterone supplementation therapy (TST) for the treatment of male hypogonadism. In this manuscript, we provide a brief review of the history of AAS and discuss clinical applications of two of the more well-known AAS: nandrolone and oxandrolone. Both agents exhibit favorable myotrophic/androgenic ratios and have been investigated for effectiveness in numerous disease states. We also provide a brief synopsis of selective androgen receptor modulators (SARMs) and postulate how these orally active, non-aromatizing, tissue-selective agents might be used in contemporary andrology. Currently, the applications of testosterone alternatives in hypogonadism are limited. However, it is tempting to speculate that these agents may one day become accepted as alternatives, or adjuncts, to the treatment of male hypogonadism.

Entities:  

Keywords:  Androgenic anabolic steroids; Hypogonadism; Nandrolone; Oxandrolone; SARMS

Mesh:

Substances:

Year:  2016        PMID: 27535042     DOI: 10.1007/s11934-016-0629-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  58 in total

1.  The history of the development of anabolic-androgenic steroids.

Authors:  Jennifer L Dotson; Robert T Brown
Journal:  Pediatr Clin North Am       Date:  2007-08       Impact factor: 3.278

Review 2.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

3.  Effect of testosterone on muscle mass and muscle protein synthesis.

Authors:  R C Griggs; W Kingston; R F Jozefowicz; B E Herr; G Forbes; D Halliday
Journal:  J Appl Physiol (1985)       Date:  1989-01

4.  Anabolic steroid users' attitudes towards physicians.

Authors:  Harrison G Pope; Gen Kanayama; Martin Ionescu-Pioggia; James I Hudson
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

Review 5.  Anabolic steroids in COPD: a review and preliminary results of a randomized trial.

Authors:  S Sharma; A Arneja; L McLean; D Duerksen; W Leslie; D Sciberras; M Lertzman
Journal:  Chron Respir Dis       Date:  2008       Impact factor: 2.444

6.  Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.

Authors:  Sherri-Ann M Burnett-Bowie; Elizabeth A McKay; Hang Lee; Benjamin Z Leder
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

Review 7.  Pharmacology of anabolic steroids.

Authors:  A T Kicman
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 8.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

Authors:  G Glazer
Journal:  Arch Intern Med       Date:  1991-10

Review 9.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

Authors:  James T Dalton; Ryan P Taylor; Michael L Mohler; Mitchell S Steiner
Journal:  Curr Opin Support Palliat Care       Date:  2013-12       Impact factor: 2.302

View more
  7 in total

Review 1.  Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.

Authors:  Zachary J Solomon; Jorge Rivera Mirabal; Daniel J Mazur; Taylor P Kohn; Larry I Lipshultz; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2018-11-30

Review 2.  Novel Therapy for Male Hypogonadism.

Authors:  Robert Carrasquillo; Kevin Chu; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2018-06-09       Impact factor: 3.092

3.  Knowledge of and Attitudes Toward the Use of Anabolic-Androgenic Steroids among the Population of Jeddah, Saudi Arabia.

Authors:  Maha H Ahmed; Najla S Al-Saud; Abdulkader M Omar; Rania M Magadmi; Sabah M Hassan; Fatma M Al-Qudsi
Journal:  J Microsc Ultrastruct       Date:  2019 Apr-Jun

Review 4.  Androgen Treatment in Adolescent Males With Hypogonadism.

Authors:  Rodolfo A Rey; Romina P Grinspon
Journal:  Am J Mens Health       Date:  2020 May-Jun

Review 5.  Recent advancement in the treatment of boys and adolescents with hypogonadism.

Authors:  Rodolfo A Rey
Journal:  Ther Adv Endocrinol Metab       Date:  2022-01-05       Impact factor: 3.565

Review 6.  Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects.

Authors:  Jack B Ding; Marcus Z Ng; Steven S Huang; Mark Ding; Kevin Hu
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2021-12-10

Review 7.  Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.

Authors:  Marco Torrisi; Giuliana Pennisi; Ilenia Russo; Francesco Amico; Massimiliano Esposito; Aldo Liberto; Giuseppe Cocimano; Monica Salerno; Giuseppe Li Rosi; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-04       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.